MicroRNA Regulation of Tumor Suppressor Mechanisms

MicroRNAs are short non-coding RNAs that modulate gene expression post-transcriptionally and have emerged as pivotal regulators of tumour suppressor pathways. By binding to complementary sequences within the 3′ untranslated regions of target mRNAs, microRNAs can inhibit translation or promote degradation, thus fine-tuning levels of proteins that guard against uncontrolled cell growth, invasion and metastatic spread. Key tumour suppressors such as PDCD4, p53 and PTEN are subject to microRNA-mediated silencing, creating complex regulatory networks that respond to cellular stress, nutrient availability and extracellular cues. Dysregulation of these microRNA–tumour suppressor interactions can tip the balance towards oncogenesis. Advances in structural biology have shed light on the molecular basis of translation inhibition by tumour suppressor proteins, while functional studies reveal how stress-sensing pathways influence tumour suppressor stability via phosphorylation–ubiquitination axes. Together, these insights are informing novel therapeutic strategies aimed at restoring tumour suppressor activity by modulating specific microRNAs or their target interactions.

Research from Nature Portfolio

High-resolution cryo-electron microscopy has delineated how the tumour suppressor PDCD4 engages the 40S ribosomal subunit at the mRNA entry channel, blocking recruitment of initiation factors and hindering scanning of structured 5′-UTRs. These structures reveal distinct roles for the N- and C-terminal domains of PDCD4 in arresting translation initiation and offer a mechanistic template for designing mimetics that reinforce its suppressive function. Complementing this, studies on metabolic stress have identified an ATP-sensing role for autophagy-related gene 7 (Atg7), which interacts with PDCD4 and AKT1 to modulate PDCD4 phosphorylation and ubiquitination. Under low ATP conditions, Atg7 inhibits AKT-mediated phosphorylation of PDCD4, preventing its ubiquitin-dependent degradation and thereby conserving energy through translational suppression. This ATP–Atg7–PDCD4 axis represents a novel homeostatic mechanism to limit apoptosis and support cell survival during metabolic stress.

MicroRNA Regulation of Tumor Suppressor Mechanisms publication trend

The graph below shows the total number of articles in microrna regulation of tumor suppressor mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

microRNA: Small non-coding RNA molecule (~21–23 nucleotides) that regulates gene expression post-transcriptionally.

Tumour suppressor: Protein or gene that inhibits uncontrolled cell proliferation, invasion and metastasis.

PDCD4 (Programmed Cell Death 4): Translation inhibitor and tumour suppressor that binds to initiation factors to block protein synthesis.

Translation initiation: Process of assembling ribosomal subunits on mRNA to begin protein synthesis.

Ubiquitination: Post-translational modification where ubiquitin tags a protein for degradation by the proteasome.

OncomiR: microRNA with oncogenic activity, promoting tumour development and progression.

References

1. Human tumor suppressor protein Pdcd4 binds at the mRNA entry channel in the 40S small ribosomal subunit. Nature Communications (2024).
2. Atg7 senses ATP levels and regulates AKT1-PDCD4 phosphorylation-ubiquitination axis to promote survival during metabolic stress. Communications Biology (2023).
3. Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells*. Journal of Biological Chemistry (2007).
4. miR-23a/b promote tumor growth and suppress apoptosis by targeting PDCD4 in gastric cancer. Cell Death & Disease (2017).